Resverlogix Corp. | Balance Sheet

Fiscal year is May-April. All values CAD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
647.50
19,635.60
35,209.30
1,852.70
155.10
Total Accounts Receivable
183.30
2,368.00
7,123.50
335.00
276.90
Inventories
-
390.00
2,316.10
4,570.90
3,917.60
Other Current Assets
448.90
316.10
1,047.20
972.20
834.50
Total Current Assets
1,279.60
22,709.70
45,696.10
7,730.70
5,184.20
Net Property, Plant & Equipment
999.80
1,189.40
1,039.70
858.70
600.00
Intangible Assets
681.50
1,328.70
2,195.80
2,920.60
2,795.90
Other Assets
360.00
397.30
1,293.90
3,348.50
2,031.90
Total Assets
3,320.90
25,625.20
50,225.50
14,858.40
10,612.00
ST Debt & Current Portion LT Debt
-
-
-
66,501.40
907.60
Accounts Payable
1,092.00
-
-
16,619.50
28,464.40
Income Tax Payable
3,405.40
-
-
-
-
Other Current Liabilities
1,838.20
27,066.60
18,300.50
12,229.10
19,284.40
Total Current Liabilities
6,335.60
27,066.60
18,300.50
95,350.00
48,656.40
Long-Term Debt
66,360.60
87,860.40
102,608.00
58,383.70
69,225.30
Total Liabilities
72,696.20
114,927.00
120,908.50
153,733.70
117,881.70
Common Equity (Total)
69,375.30
89,301.80
70,683.00
138,875.30
107,269.70
Total Shareholders' Equity
69,375.30
89,301.80
70,683.00
138,875.30
107,269.70
Total Equity
69,375.30
89,301.80
70,683.00
138,875.30
107,269.70
Liabilities & Shareholders' Equity
3,320.90
25,625.20
50,225.50
14,858.40
10,612.00

About Resverlogix

View Profile
Address
4820 Richard Road SW
Calgary Alberta T3E 6L1
Canada
Employees -
Website http://www.resverlogix.com
Updated 07/08/2019
Resverlogix Corp. is a clinical stage biotechnology company, which engages in the research and development of pharmaceutical products for cardiovascular diseases. It develops Apabetalone for diabetes mellitus, chronic kidney, peripheral artery, Orphan and Alzheimer's diseases. The company was founded by Donald J.